LKST
Leukosite Inc
Biopharmaceutical company developing monoclonal antibody therapies for oncology and inflammatory diseases; acquired by Millennium Pharmaceuticals in December 1999
CUSIP: 52728R102HealthcareUS1 holder
Leukosite Inc
Biopharmaceutical company developing monoclonal antibody therapies for oncology and inflammatory diseases; acquired by Millennium Pharmaceuticals in December 1999
No financial data available for this security.